Form 4 Filing for Mary K. Moreland, Executive Vice President of Abbott Laboratories

This Form 4 filing details a transaction by Mary K. Moreland, Executive Vice President of Abbott Laboratories (ABT). On April 28, 2026, Moreland acquired 5,314 common shares without par value at a price of $94.41 per share. This acquisition was made through a profit-sharing trust, with the transaction code 'I' indicating an "Insider Transaction". Following this transaction, the number of shares held in the trust is 17,159. Additionally, Moreland directly holds 104,291 shares. The filing is signed by Mary K. Moreland, represented by an attorney-in-fact, on April 29, 2026, reporting on the period ending April 28, 2026. The shares acquired were part of the Abbott Laboratories Stock Retirement Trust.